Is Inogen Inc (INGN) overvalued? · rev $335.7M
Inogen Inc (INGN) is a medical devices company listed on US.
This page asks whether Inogen Inc (INGN) looks expensive on cached numbers — not a short thesis.
Latest reported INGN revenue for 2024-12-31 was $335.7M. Net income was -$35.9M. Revenue was up 6.4% from 2023-12-31 to 2024-12-31. INGN currently screens at market cap $173.5M.
INGN currently screens at market cap $173.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next INGN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the INGN stock page for the full model, not this heading.
Not investment advice.